Anti-Bullous Pemphigoid Antibodies in Patients with Neurological Disease


About this study

The purpose of this study is to learn more about Lewy Body disease and a skin condition called Bullous Pemphigoid.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Blood sample (serum) from patients with Lewy Body Dementia will be done prospectively in collaboration with our co-investigators in the Department of Neurology


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Carilyn Wieland, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions